0000950170-24-068759.txt : 20240604 0000950170-24-068759.hdr.sgml : 20240604 20240604164209 ACCESSION NUMBER: 0000950170-24-068759 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240601 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dunsire Deborah CENTRAL INDEX KEY: 0001332764 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 241018854 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 ownership.xml 4 X0508 4 2024-06-01 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001332764 Dunsire Deborah C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 true false false false false Common Stock 2024-06-01 4 M false 4000 A 12000 D Restricted Stock Units 2024-06-01 4 M false 4000 0.00 D Common Stock 4000 0 D Represents shares of common stock received upon vesting of a restricted stock unit ("RSU") award. Each RSU represents the contingent right to receive one share of the issuer's common stock. These RSUs vested in their entirety on the first anniversary of the date of grant of the award. /s/ Todd Rosenthal, as attorney-in-fact 2024-06-04